A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma

2020 ◽  
Vol 106 (3) ◽  
pp. 564-570 ◽  
Author(s):  
Lara A. Dunn ◽  
Nadeem Riaz ◽  
Matthew G. Fury ◽  
Sean M. McBride ◽  
Loren Michel ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document